Abstract: The container for disposal of cigarette waste includes a base, a hollow stem having an outer wall that contains an interior cavity of the hollow stem. The stem further includes a top and a bottom, where the stem is coupled to the base at the bottom. The container also includes a removable cap which is detachably coupled to the top of the stem. It further includes a disposal bucket attached to the cap. Once the cap is coupled to the top of the stem, the disposal bucket is suspended in the interior cavity of the stem. At least one hole is made through the outer wall of the stem near the top. Once the disposal bucket is placed in the interior cavity of the stem, the hole is located between disposal bucket and the cap.

Abstract: A shop desk with a desk body sized to define a volume bounded by a top, front, rear and side walls. A hutch is configured to fit within the volume when disassembled. The desk body is wider, longer and deeper than the hutch. The hutch secures to a top surface of the desk body when assembled. Legs support the desk body and a leg stabilizer platform connects to the legs at a location spaced from an underside of the desk body.

Abstract: A method for isolating the bioactive component of the water-soluble extract of Uncaria tomentosa known as C-MED-100®, comprising (i) precipitating the spray drying carrier from C-MED-100®; (ii) using the resulting C-MED-100® to obtain a spotting mixture for thin layer chromatography (TLC); (iii) spotting the C-MED-100® spotting mixture on pre-run TLC plates and eluting the plates to obtain the fluorescing band with Rf=0.2-0.3; (iv) scraping off the Rf=0.2-0.3 band, eluting it in ammonia and freeze drying the eluted band to form a powder; and (v) extracting the powder with methanol to remove solubilized silica gel, concentrating the methanol solution and crystallizing the concentrated solution to obtain the bioactive component. The isolated bioactive component in vitro is a quinic acid analog, preferably quinic acid lactone. By contrast, the isolated bioactive component in vivo is quinic acid, whether as free acid or as a quinic acid salt, including quinic acid ammonium salt.

Abstract: A method for isolating the bioactive component of the water-soluble extract of Uncaria tomentosa known as C-MED-100®, comprising (i) precipitating the spray drying carrier from C-MED-100®; (ii) using the resulting C-MED-100® to obtain a spotting mixture for thin layer chromatography (TLC); (iii) spotting the C-MED-100® spotting mixture on pre-run TLC plates and eluting the plates to obtain the fluorescing band with Rf=0.2-0.3; (iv) scraping off the Rf=0.2-0.3 band, eluting it in ammonia and freeze drying the eluted band to form a powder; and (v) extracting the powder with methanol to remove solubilized silica gel, concentrating the methanol solution and crystalizing the concentrated solution to obtain the bioactive component. The isolated bioactive component is a quinic acid analog, preferably quinic acid lactone. A pharmaceutical composition comprising a pharmaceutically effective amount of the bioactive component and a nontoxic inert carrier or diluent.

Abstract: Two drums are arranged so that a head of each faces each other in close proximity to enable a distal end of a drum stick, hand or mallet that is positioned between them to strike both when moving the drum stick, hand or mallet first toward and against one and then toward and against the other.